

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Insomnia Insomnia is a common sleep disorder in which there is difficulty in falling or staying asleep at night. ZANLOP 5MG CAPSULE helps treat insomnia as well as improves the quality of sleep. ZANLOP 5MG CAPSULE works by slowing activity in the brain to allow sleep. This helps you relax and feel more energetic. It also helps you concentrate better and improves your quality of life.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. ZANLOP 5MG CAPSULE is to be taken empty stomach.
ZANLOP 5MG CAPSULE is a nonbenzodiazepine hypnotic. Along with sedative, it may also have anxiolytic (panic-reducing or antianxiety), muscle relaxant properties. It works by binding GABA-A/chloride ion channel receptor complex (receptor), thus relaxes the nerves and brain. This is how it helps you to fall asleep.
Unsafe: Avoid consuming alcohol with ZANLOP 5MG CAPSULE as it is deemed unsafe.
Seek medical advice from your doctor: ZANLOP 5MG CAPSULE may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: ZANLOP 5MG CAPSULE is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: ZANLOP 5MG CAPSULE may cause side effects which could affect your ability to drive.
Caution Advised: ZANLOP 5MG CAPSULE should be used with caution in patients with severe kidney disease. Dose adjustment of ZANLOP 5MG CAPSULE may be needed. Doctor consultation is advised. Limited information is available on the use of ZANLOP 5MG CAPSULE in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Caution Advised: ZANLOP 5MG CAPSULE should be used with caution in patients with liver disease. Dose adjustment of ZANLOP 5MG CAPSULE may be needed. Doctor consultation is advised. Use of ZANLOP 5MG CAPSULE is not recommended in patients with severe liver disease.
If you forget a dose of ZANLOP 5MG CAPSULE , simply continue with your regular schedule and do not take a double dose.
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Stahl SM, editor. Zaleplon. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 739-41
Mihic SJ, Harris RA. Hypnotics and Sedatives. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 467
Trevor AJ, Way WL. Sedative-Hypnotic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 381
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1503-504
Zalepon. Sellersville, PA: TEVA PHARMACEUTICALS USA; 2008 (19 Mar. 2019)
Drugs and Lactation Database (LactMed) (20 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.